Astria Therapeutics (ATXS)
(Delayed Data from NSDQ)
$12.23 USD
+0.21 (1.75%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $12.22 -0.01 (-0.08%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.43 |
Last EPS Surprise | -16.22% |
ABR | 1.00 |
Earnings ESP
|
-4.56% |
---|---|
Current Year | -1.66 |
Next Year | -1.76 |
EPS (TTM) | -2.30 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.44 | -1.66 | -1.76 |
# of Estimates | 5 | 5 | 6 | 5 |
Most Recent Consensus | -0.47 | -0.53 | -1.82 | -1.80 |
High Estimate | -0.35 | -0.34 | -1.34 | -1.52 |
Low Estimate | -0.47 | -0.53 | -1.95 | -1.91 |
Year ago EPS | -0.63 | -0.86 | -2.42 | -1.66 |
Year over Year Growth Est. | 31.75% | 48.84% | 31.40% | -6.27% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 4 | 4 | 4 | 2 |
Down Last 60 Days | 4 | 4 | 4 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.44 | -1.66 | -1.76 |
7 Days Ago | -0.43 | -0.44 | -1.66 | -1.76 |
30 Days Ago | -0.40 | -0.41 | -1.62 | -1.80 |
60 Days Ago | -0.40 | -0.41 | -1.56 | -1.79 |
90 Days Ago | -0.40 | -0.41 | -1.56 | -1.79 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.46 | -1.67 | -1.82 |
Zacks Consensus Estimate | -0.43 | -0.44 | -1.66 | -1.76 |
Earnings ESP | -4.56% | -5.51% | -0.45% | -2.99% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.43 | -0.38 | -0.86 | -0.63 | NA |
Estimate | -0.37 | -0.35 | -0.69 | -0.51 | NA |
Difference | -0.06 | -0.03 | -0.17 | -0.12 | -0.10 |
Surprise | -16.22% | -8.57% | -24.64% | -23.53% | -18.24% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more